{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:05:17Z","timestamp":1777615517903,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemosphere"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.chemosphere.2014.01.011","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T09:00:18Z","timestamp":1392022818000},"page":"95-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"special_numbering":"C","title":["Human pharmaceutical products in the environment \u2013 The \u201cproblem\u201d in perspective"],"prefix":"10.1016","volume":"115","author":[{"given":"David","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Senac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemosphere.2014.01.011_b0005","unstructured":"Ayscough, N.J., Fawell, J., Franklin, G., Young, W., 2000. Review of Human Pharmaceuticals in the Environment. UK Environment Agency R&D Technical Report P390."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10408440903373590","article-title":"Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish","volume":"40","author":"Corcoran","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0015","doi-asserted-by":"crossref","first-page":"e19069","DOI":"10.1371\/journal.pone.0019069","article-title":"Effectiveness of action in india to reduce exposure of Gyps vultures to the toxic veterinary drug diclofenac","volume":"6","author":"Cuthbert","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.chemosphere.2014.01.011_b0020","unstructured":"EMA (European Medicines Agency), 2013. Summary of Opinion (initial authorisation) Tecfidera Dimethyl fumarate (EMA\/167897\/2013)."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0025","unstructured":"EU (European Union), 2012. Commission Regulation (EU) No. 412\/2012 of 15 May 2012 amending Annex XVII to Regulation (EC) No 1907\/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) Official Journal L128 1\u20133."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0030","unstructured":"Grung, M., Eldbj\u00f8rg, S., Heimstad, M.M., Schlabach, M., Svenson, A., Thomas, K., Woldegiorgis, A., 2007. Human and Veterinary Pharmaceuticals, Narcotics, and Personal Care Products in the Environment. SFT, Report TA-2325\/2007."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0035","unstructured":"HMA (Heads of Medicines Agency), 2012. HMA\/EMA Guidance Document on the Identification of Commercially Confidential Information and Personal Data within the Structure of the Marketing Authorisation (MA) Application: Release of Information after the Granting of a Marketing Authorisation. European Medicines Agency, 2012. <http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2012\/03\/news_detail_001478.jsp&mid=WC0b01ac058004d5c1>."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40264-013-0049-3","article-title":"Ecopharmacovigilance \u2013 what could it mean in practice?","volume":"36","author":"Holm","year":"2013","journal-title":"Drug Safety"},{"key":"10.1016\/j.chemosphere.2014.01.011_b0045","series-title":"Late Lessons from Early Warnings: Science, Precaution, Innovation","first-page":"311","article-title":"Ethinyl estradiol: bitter pill for the precautionary principle","author":"Jobling","year":"2013"},{"key":"10.1016\/j.chemosphere.2014.01.011_b0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jhazmat.2007.07.008","article-title":"Effluent from drug manufactures contains extremely high levels of pharmaceuticals","volume":"148","author":"Larsson","year":"2007","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0055","unstructured":"Mattson, B., Nasmen I., Strom, J., 2008, Sweden\u2019s voluntary environmental drug classification system. RAJ Pharma March, 138\u2013153."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ieam.1268","article-title":"Managing emissions of active pharmaceutical ingredients from manufacturing facilities: an environmental quality standard approach","volume":"8","author":"Murray-Smith","year":"2012","journal-title":"Integr. Environ. Assess. Manage."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0065","unstructured":"Park, J., 2005. Pharmaceuticals in the Environment and Management Approaches in Korea. Korea Environment Institute Report KEI 2005 RE-12."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02757549408038554","article-title":"Estrogenic effects of effluents from sewage treatment works","volume":"8","author":"Purdom","year":"1994","journal-title":"Chem. Ecol."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2042-7158.1985.tb04922.x","article-title":"The fate of pharmaceutical chemicals in the aquatic environment","volume":"37","author":"Richardson","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0080","series-title":"Pharmaceuticals in the Environment: Current Knowledge and Need Assessment to Reduce Presence and Impact","author":"Roig","year":"2010"},{"key":"10.1016\/j.chemosphere.2014.01.011_b0085","unstructured":"SMPA (Swedish Medical Products Agency), 2004. Environmental Effects of Pharmaceuticals, Cosmetics and Hygiene Products. Official report from the Swedish Medical Products Agency."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1289\/ehp.95103s7173","article-title":"Vitellogenesis as a biomarker of oestrogenic contamination of the aquatic environment","volume":"103","author":"Sumpter","year":"1995","journal-title":"Environ. Health Persp."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1039\/b815741n","article-title":"10th anniversary perspective: reflections on endocrine disruption in the aquatic environment: from known knowns to unknown unknowns (and many things in between)","volume":"10","author":"Sumpter","year":"2008","journal-title":"J. Environ. Monit."},{"key":"10.1016\/j.chemosphere.2014.01.011_b0100","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/11539380-000000000-00000","article-title":"Ecopharmacovigilance for better health","volume":"33","author":"Velo","year":"2010","journal-title":"Drug Safety"}],"container-title":["Chemosphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045653514000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045653514000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T15:26:43Z","timestamp":1538839603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045653514000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":20,"alternative-id":["S0045653514000770"],"URL":"https:\/\/doi.org\/10.1016\/j.chemosphere.2014.01.011","relation":{},"ISSN":["0045-6535"],"issn-type":[{"value":"0045-6535","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human pharmaceutical products in the environment \u2013 The \u201cproblem\u201d in perspective","name":"articletitle","label":"Article Title"},{"value":"Chemosphere","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemosphere.2014.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}